2014		2015		2016		Rate(Cases per 100,000 per quarter)		Quarterly Rate Comparison
Disease	Q3 No.	YTD No.	Q3 No.	YTD No.	Q3 No.	YTD No.	Qtr3 (2011-2015 aggregated)	Qtr3 (2016)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	5	11	5	17	6	21	0.13	0.28
HEPATITIS A	.	.	.	8	.	9	0.08	0.09
HEPATITIS B (ACUTE)	.	13	7	14	.	11	0.22	0.14
INFLUENZA**	12	514	6	452	.	504	0.29	0.09
MEASLES	0	0	0	9	0	0	0.00	0.00
MUMPS	.	.	0	0	0	.	0.02	0.00
PERTUSSIS	8	48	12	80	.	22	1.01	0.09	X
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
CHLAMYDIA	2587	7713	2611	7477	2949	8188	118.53	138.98	X
GONORRHEA	736	1977	827	2186	956	2551	31.42	45.06	X
HIV	67	214	82	235	0	169	3.26	0.00	X
SYPHILIS (EARLY LATENT)	88	231	118	293	79	348	3.40	3.72
SYPHILIS (PRIMARY & SECONDARY)	73	206	73	211	75	237	2.42	3.53	X
Stage 3 HIV (AIDS)	45	160	44	129	0	95	2.42	0.00	X
ENTERICS
AMEBIASIS	.	.	6	10	.	.	0.13	0.05
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.00	0.00
CAMPYLOBACTERIOSIS	35	80	34	82	25	78	1.39	1.18
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	0	.	.	.	.	.	0.06	0.05
GIARDIA	12	30	.	23	11	34	0.71	0.52
ROTAVIRUS	5	47	.	65	5	29	0.31	0.24
SALMONELLOSIS	50	93	63	136	34	107	2.48	1.60
SHIGA-TOXIN PRODUCING E. COLI#	9	17	18	30	10	36	0.73	0.47
SHIGELLOSIS	9	18	12	21	18	39	0.92	0.85
TYPHOID FEVER	0	.	.	.	0	.	0.02	0.00
VIBRIO (NON-CHOLERA)	0	.	.	.	.	.	0.07	0.09
YERSINIOSIS	0	.	0	0	.	.	0.04	0.05
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	0	0	.	0.00	0.00
COCCIDIOIDOMYCOSIS	9	46	22	61	13	48	0.93	0.61
DENGUE FEVER	0	.	.	.	.	.	0.03	0.05
ENCEPHALITIS	.	.	0	.	.	.	0.02	0.09
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	0	.	.	.	0	0	0.01	0.00
HEPATITIS C (ACUTE)	.	.	.	7	.	15	0.03	0.19
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.##	0	0	0	0	0	0	0.00	0.00
LEGIONELLOSIS	11	17	.	18	12	20	0.30	0.57
LEPROSY (HANSEN’S DISEASE)	0	.	0	0	0	0	0.00	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	0	.	0	.	.	.	0.02	0.05
LYME DISEASE	.	.	.	5	.	7	0.09	0.14
MALARIA	5	7	.	.	.	5	0.12	0.05
MENINGITIS, ASEPTIC/VIRAL	13	32	8	27	10	18	0.50	0.47
MENINGITIS, BACTERIAL	.	10	.	14	6	29	0.09	0.28
MENINGOCOCCAL DISEASE	0	.	0	0	.	.	0.00	0.05
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	0	0	.	0.00	0.00
Q FEVER	0	0	0	.	.	.	0.00	0.05
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	0	0	.	.	0.00	0.09
RSV (RESPIRATORY SYNCYTIAL VIRUS)	18	613	10	1103	5	663	0.70	0.24	X
STREPTOCOCCUS PNEUMONIAE, IPD###	15	64	10	75	14	103	0.47	0.66
TOXIC SHOCK SYN	0	0	0	0	0	0	0.00	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	.	9	.	8	.	13	0.04	0.09
TUBERCULOSIS	20	56	12	59	0	17	0.85	0.00	X
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (ENCEPHALITIS)	.	.	.	.	.	.	0.21	0.05
WEST NILE VIRUS (FEVER)	0	0	0	0	0	0	0.03	0.00
ZIKA VIRUS DISEASE, CONGENITAL~	0	0	0	0	0	0	0.00	0.00
ZIKA VIRUS DISEASE, NON-CONGENITAL~	0	0	0	0	.	11	0.00	0.19
ZIKA VIRUS INFECTION, CONGENITAL~	0	0	0	0	0	0	0.00	0.00
ZIKA VIRUS INFECTION, NON-CONGENITAL~	0	0	0	0	0	0	0.00	0.00

*Due to software transition STD data since 2014 are not comparable with those in previous years. Rate denominators are interpolated population estimates/projections using demographic data under ongoing revisions by the state demographer. Use of onset date in data aggregation for cases other than STD or TB (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS/TB case counts provided by Office of Disease Surveillance. Data suppression denoted by ‘.’ applies if number of cases <5. Quarterly disease total (excluding STD and TB cases)=246(reported total=4215). Quarterly congenital syphilis cases (suppression applied) for 2014-2016 were .,.,.(YTD totals of .,.,7) respectively.
~Zika case definitions added in 2016.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).